Lens Dislocation in Marfan Syndrome

Total Page:16

File Type:pdf, Size:1020Kb

Load more

CLINICOPATHOLOGIC REPORTS, CASE REPORTS, AND SMALL CASE SERIES SECTION EDITOR: W. RICHARD GREEN, MD tion of the oil progressing through the In January 2001, glaucoma sur- Silicone Oil Egressing tube and histopathologic analysis of gery was needed to control elevated Through an Inferiorly the orbital tissue surrounding the ex- intraocular pressure (IOP). The eye Implanted Ahmed Valve truded silicone oil. was aphakic and had total traumatic aniridia. An Ahmed valve was im- Silicone oil use as an adjunct to com- Report of a Case. A 69-year-old white planted inferonasally in an attempt plicated vitreoretinal surgery is be- man lost his left eye to trauma at age to avoid the silicone oil bubble coming more frequent. Refractory 12 years. In September 2000, blunt (Figure 1 and Figure 2). The pa- glaucoma in these patients is com- trauma resulted in a lacerated eye- tient’s IOP responded well initially mon. Isolated reports have men- brow, scleral rupture, uveal prolapse, but rose subsequently to 30 mm Hg. tioned the possibility of silicone oil extrusion of his crystalline lens, reti- A bubble of silicone oil was wrap- migrating and/or obstructing the nal detachment, and suprachoroidal ping the tip of the tube (Figure 3). tube in the anterior chamber of Mol- hemorrhage in his right eye. A limited Silicone oil could be seen migrating teno implants (IOP, Costa Mesa, anterior chamber washout was per- through the Ahmed tube (Figure 4 Calif).1,2 This report describes a case formed at the time of the primary re- and Figure 5) and the bleb over the of intraocular silicone oil egressing pair. Ten days later, he underwent implant progressively enlarged and through an Ahmed implant (New pars plana vitrectomy, silicone oil in- appeared encapsulated during the World Medical, Rancho Cucamonga, jection, and a scleral buckle. A pars next few months. A glistening mate- Calif), impairing the functioning of plana vitrectomy revision with endo- rial was noted in cystic spaces over- the tube and requiring replacement laser,membranestripping,andsilicone lying the Ahmed implant under the of the implant plus oil removal. We oilreinjectionwereperformed1month conjunctiva. An inferior ectropion present photographic documenta- laterforarecurrentretinaldetachment. that progressed gradually was also Figure 1. Slitlamp photograph showing the Ahmed tube inferonasally short Figure 2. Retroillumination photograph showing a patent Ahmed tube. after implantation. Notice total traumatic aniridia and superotemporal paralimbal scleral wound with interrupted sutures. Figure 3. Slitlamp photograph showing “candle wax” appearance of the Figure 4. Retroillumination photograph showing a level of silicone oil silicone oil wrapped around the tip of the Ahmed tube. (arrow) inside the Ahmed tube. (REPRINTED) ARCH OPHTHALMOL / VOL 120, JUNE 2002 WWW.ARCHOPHTHALMOL.COM 831 ©2002 American Medical Association. All rights reserved. Downloaded From: https://jamanetwork.com/ on 10/02/2021 Figure 5. Retroillumination photograph taken on a different day shows a Figure 6. Histopathologic examination of orbital tissue excised during different level of silicone oil (arrow) inside the Ahmed tube. removal of valve shows empty vacuoles consistent with silicone oil and larger deposit of oil surrounded by epithelioid histiocytes and foreign body giant cells (hematoxylin-eosin, original magnification ϫ200). noted. The volume of the silicone the migration of the silicone oil It seems that a “unicameral” eye bubble in the vitreous cavity de- through the Ahmed implant. The in- with silicone oil, particularly with sig- creased from an estimated 85% fill to flammatory reaction observed in the nificant iris defects, is a poor candi- an estimated 50% fill. Ectropion re- periocular tissues, apparently caused date for successful IOP control with pair was necessary in June 2001. by the silicone oil, has been docu- a seton in a 1-stage procedure. In our Owing to persistently elevated mented before.1,2 This contrasts with case, the inferior location of the im- IOP measurements, transcorneal re- no observed clinical reaction in in- plant did not prevent silicone oil moval of the silicone oil combined traocular tissues, although histo- movement out of the eye with sec- with replacement of the Ahmed im- pathologically foreign-body granu- ondary impairment of IOP control. plant was performed. Multiple sili- lomas have been documented in Silicone oil removal needs to be con- cone oil–filled conjunctival cysts intraocular tissues. sidered prior to implantation of a se- were found surrounding the Ahmed The silicone oil did impair the ton in such cases. If silicone oil re- plate. A tissue sample was taken in- drainage of aqueous through the im- moval is not an option, diode laser ferotemporally from a thick cap- plant as evidenced by the elevated cyclophotocoagulation is another al- sule surrounding the Ahmed im- IOPs. Encapsulation of the bleb might ternative for IOP control. plant. Histopathologic analysis of the also have contributed to the obstruc- tissue surrounding the plate dem- tion of the implant. The photographs Jose Morales, MD onstrated fibroconnective tissue with (Figures 3 and 4), showing oil at dif- Michel Shami, MD numerous small vacuoles. Surround- ferent levels of the tube, demonstrate Geert Craenen, MD ing this tissue were numerous for- the progression of the silicone oil Thom F. Wentlandt, CRA eign-body giant cells and histio- through the tube of the Ahmed im- Lubbock, Tex cytes (Figure 6). plant. We believe that aphakia with total aniridia resulted in an anatomic Corresponding author: Jose Morales, Comment. To our knowledge, this situation (a truly unicameral eye) that MD, Texas Tech University Health Sci- is one of the first documented cases favored the anterior migration of the ences Center, Department of Ophthal- of silicone oil exiting the eye through silicone oil when the patient inadvert- mologyandVisualSciences,3601Fourth an Ahmed implant. Review of the lit- ently assumed a supine position. This St, STOP 7217, Lubbock, TX 79430- erature yielded 2 previous reports, was probably favored by the well- 7217(e-mail:[email protected]). both involving Molteno implants in known physical attraction of the sili- aphakic patients1,2 and 1 recent re- conetubetowardthesiliconeoil.Once 1. Hyung SM. Min JP. Subconjunctival silicone oil 3 drainage through the Molteno implant. KorJOph- port involving an Ahmed implant. an oil bubble made it to the entrance thalmol. 1998;12:73-75. Minckler4 describes adhesion of the ofthetube,thecombinedeffectofcap- 2. Senn P, Buchi ER, Daicher B, Schipper I. Bubbles silicone oil to the anterior chamber illary action with elevated IOP may in the bleb: troubles in the bleb? molteno im- plant and intraocular tamponade with silicone portion of the drainage tube, resem- have facilitated the migration of the oil in an aphakic patient. Ophthalmic Surg. 1991; bling candle wax, without lumen ob- oil to the subconjunctival space. The 26:379-382. 3. Nazemi PP, Chong LP, Varma R, Burnstine MA. struction. He recommends placing patient’s IOP has been under control Migration of intraocular silicone oil into the sub- the tube in an inferior location to since replacement of the Ahmed im- conjunctival space and orbit through an Ahmed minimize the chance of oil-tube ob- plant and removal of the silicone oil. glaucoma valve. Am J Ophthalmol. 2001;132: 929-931. struction. In our case, the inferior lo- His last corrected visual acuity was 20/ 4. Minckler D. Silicone oil glaucoma: cases in con- cation of the tube did not prevent 50 OD. troversy. J Glaucoma. 2001;10:51-54. (REPRINTED) ARCH OPHTHALMOL / VOL 120, JUNE 2002 WWW.ARCHOPHTHALMOL.COM 832 ©2002 American Medical Association. All rights reserved. Downloaded From: https://jamanetwork.com/ on 10/02/2021 olol administered daily. The pa- utes, and then washed in Tris- Lens Dislocation tient’s grandfather, cousin, and buffered saline. The sections were in Marfan Syndrome: mother also had Marfan syndrome. incubated with a 1:5 dilution of pre- Potential Role of Matrix Her mother developed bilateral lens immune serum from the secondary Metalloproteinases in subluxation and glaucoma. A sys- host species. Tissue sections were in- temic examination revealed arachno- cubated with 1:100 goat primary poly- Fibrillin Degradation dactyly and a high arched palate. clonal antifibrillin antibody (Santa Ophthalmologic examination re- Cruz Biotechnology, Santa Cruz, Marfan syndrome is an autosomal vealed a best-corrected visual acuity Calif) and 1:100 mouse primary dominant disorder with pleiotro- of 20/220 OD and 20/120 OS. The monoclonal anti-MMP–1, anti- pic manifestations that involve the right eye had an intraocular pres- MMP–2, anti-MMP–3, anti-MMP–9 ocular, cardiovascular, and skeletal sure of 19 mm Hg; and the left eye, (ICN Pharmaceuticals, Costa Mesa, systems. Marfan syndrome re- 18 mm Hg. Goldmann visual fields Calif), 1:100 TIMP-1, TIMP-2 (ICN), mains primarily a clinical diagno- were normal. Slitlamp examination and 1:100 TIMP-3 (Calbiochem, San sis with a frequency of 2 to 3 indi- confirmed bilateral superonasal lens Diego, Calif) overnight at 4°C. The viduals per 10000. Patients with this subluxation that was worse in the sections were then washed in 0.05M disorder may have a variety of ocu- right eye than in the left (Figure). Tris-buffered saline (pH, 7.6) before lar complaints, most commonly, The fundus was normal, with cup- the addition of a biotinylated rabbit subluxation of the lens, which oc- disc ratios of 0.2 for each eye. The antigoat secondary antibody (for curs in more than 60% of patients.1 ocular examination was otherwise fibrillin) and biotinylated goat anti- Several studies have identified the normal. Because of the advanced zo- mouse secondary antibody (for MMPs FBN1 fibrillin gene located on chro- nular dialysis, bilateral intracapsular and TIMPs). The antibodies di- mosome 15 as defective in this syn- lens extractions were performed with rected against human antigens dis- 2 ␣ drome. a cryoprobe and without -chymo- play no cross-reactivity and are all IG1 Matrix metalloproteinases trypsin.
Recommended publications
  • Climate Change and Human Health: Risks and Responses

    Climate Change and Human Health: Risks and Responses

    Climate change and human health RISKS AND RESPONSES Editors A.J. McMichael The Australian National University, Canberra, Australia D.H. Campbell-Lendrum London School of Hygiene and Tropical Medicine, London, United Kingdom C.F. Corvalán World Health Organization, Geneva, Switzerland K.L. Ebi World Health Organization Regional Office for Europe, European Centre for Environment and Health, Rome, Italy A.K. Githeko Kenya Medical Research Institute, Kisumu, Kenya J.D. Scheraga US Environmental Protection Agency, Washington, DC, USA A. Woodward University of Otago, Wellington, New Zealand WORLD HEALTH ORGANIZATION GENEVA 2003 WHO Library Cataloguing-in-Publication Data Climate change and human health : risks and responses / editors : A. J. McMichael . [et al.] 1.Climate 2.Greenhouse effect 3.Natural disasters 4.Disease transmission 5.Ultraviolet rays—adverse effects 6.Risk assessment I.McMichael, Anthony J. ISBN 92 4 156248 X (NLM classification: WA 30) ©World Health Organization 2003 All rights reserved. Publications of the World Health Organization can be obtained from Marketing and Dis- semination, World Health Organization, 20 Avenue Appia, 1211 Geneva 27, Switzerland (tel: +41 22 791 2476; fax: +41 22 791 4857; email: [email protected]). Requests for permission to reproduce or translate WHO publications—whether for sale or for noncommercial distribution—should be addressed to Publications, at the above address (fax: +41 22 791 4806; email: [email protected]). The designations employed and the presentation of the material in this publication do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries.
  • OCT WORLD Pushing the Boundaries of Optical Coherence Tomography Technology from Our Chair, Edward G

    OCT WORLD Pushing the Boundaries of Optical Coherence Tomography Technology from Our Chair, Edward G

    visionDuke Eye Center 2016 It’s an OCT WORLD pushing the boundaries of optical coherence tomography technology From our Chair, Edward G. Buckley, MD 2 10 24 2016 VOLUME 32 hat an amazing first year as Chairman of the Department of Ophthalmology. There have been so many exciting events over the past year. 2 50 Years of Duke Ophthalmology 1 Message from the Chair W . The Department celebrated its 50th anniversary 24 Development News 4 Hudson Building at Duke Eye Center in 2015. 36 Faculty Awards and News COVER STORY . A long-planned dream came true with the opening of our state-of-the-art clinical facility, the Hudson 10 It’s an OCT World 38 New Faculty Building at Duke Eye Center. 16 Innovative Macular Surgery 40 Administration, Faculty and Staff . Our faculty won awards, had clinical breakthroughs, and made advances in several 20 Duke Eye Center by the Numbers areas. While ophthalmology has been an important part of 22 The Art of Reconstructive Surgery Duke Medical Center since the 1940’s, the stand-alone 26 Pediatric Glaucoma Patient Sets Out to Help Others department was established in 1965. With the appointment and vision of Joseph A. C. Wadsworth, MD, the first 01 27 Expanding Ocular Oncology chairman of the Department of Ophthalmology, Duke Eye Center was established and initiated the three-building 28 Center for Macular Diseases Studying New Treatments for AMD campus that we have today. I hope you enjoy reading more about our history and the timeline of events over the last 30 New Partnership Accelerates Research on Glaucoma Genetics 50 years.
  • Evaluation of Humeral and Glenoid Bone Deformity in Glenohumeral Arthritis 5

    Evaluation of Humeral and Glenoid Bone Deformity in Glenohumeral Arthritis 5

    Evaluation of Humeral and Glenoid Bone Deformity 1 in Glenohumeral Arthritis Brian F. Grogan and Charles M. Jobin Introduction glenoid bone wear helps the surgeon formulate a successful treatment plan and surgical goals Glenohumeral arthritis is the sequela of a vari- to address the pathoanatomy and improve the ety of pathologic shoulder processes, most durability of shoulder arthroplasty. The evalu- commonly degenerative osteoarthritis, but may ation of humeral and glenoid bone deformity also be secondary to post-traumatic conditions, in glenohumeral arthritis has profound surgical inflammatory arthritis, rotator cuff tear arthrop- implications and is fundamental to successful athy, and postsurgical conditions most com- shoulder arthroplasty. monly post-capsulorrhaphy arthritis. Patients with glenohumeral arthritis commonly demon- strate patterns of bony deformity on the glenoid Glenoid Deformity in Osteoarthritis and humerus that are caused by the etiology of the arthritis. For example, osteoarthritis com- Glenoid deformity and glenohumeral subluxation monly presents with posterior glenoid wear, are commonly seen in the setting of primary osteo- secondary glenoid retroversion, and posterior arthritis of the glenohumeral joint. The glenoid humeral head subluxation, while inflammatory wear tends to occur posteriorly and may be best arthritis routinely causes concentric glenoid viewed on axial radiographs or computed tomog- wear with central glenoid erosion. A thorough raphy (CT) axial images. Glenoid erosion, as first history and physical, as well as laboratory and characterized by Walch, is noted to be either central radiographic workup, are keys to understanding or posterior, with varying degrees of wear and pos- the etiology of arthritis and understanding the terior subluxation of the humerus [1, 2] (Fig.
  • Peroneal Tendon Subluxation

    Peroneal Tendon Subluxation

    CHAPTER 4 Peroneal Tendon Subluxation Jessica Lickiss, DPM Jay D. Ryan, DPM INTRODUCTION Peroneal tendon subluxation/ instability can be challenging IMAGING AND CLASSIFICATION to diagnose depending on the level of disruption and deformity present. Subtle cases will appear in the clinical Radiographs can be used to identify an avulsion and rule out setting similar to a lateral ankle sprain. This can cause a delay fracture. Computed tomography (CT) scan and MRI are in care and poorer outcomes for patients. both viable options for evaluation. MRI better evaluates the health of the peroneal tendons and CT scan demonstrates ANATOMY the shape and position of the fibula and fibular groove. While advanced imaging is a great adjunct, the diagnosis is mainly The peroneus longus and brevis muscle bellies travel clinical. For more subtle injuries where the tendons do not posterior to the fibula and fibular groove. At the fibular completely sublux or dislocate the fibula, dynamic ultrasound groove they are combined into one sheath; they separate can be used for diagnosing intrasheath instability (5). usually at the level of the peroneal tubercle. They are bound Eckert and Davis created a classification in 1976 for superiorly by the superior peroneal retinaculum (SPR) and SPR injuries (6). Grade I injuries involve elevation of the inferiorly by the calcaneofibular ligament (CFL) and the retinaculum from the lateral malleolus and the tendons inferior peroneal retinaculum (IPR). The superior peroneal can dislocate between the bone and periosteum. Grade II retinaculum has fibers that extend superiorly, posteriorly, injuries involve the fibrocartilaginous ridge elevating with and medially approximately 3.5 cm from the distal tip of the the retinaculum and tendon subluxed between it and the fibula (1).
  • Microcurrent Stimulation in the Treatment of Dry and Wet Macular Degeneration

    Microcurrent Stimulation in the Treatment of Dry and Wet Macular Degeneration

    Journal name: Clinical Ophthalmology Article Designation: Original Research Year: 2015 Volume: 9 Clinical Ophthalmology Dovepress Running head verso: Chaikin et al Running head recto: Microcurrent stimulation for macular degeneration treatment open access to scientific and medical research DOI: http://dx.doi.org/10.2147/OPTH.S92296 Open Access Full Text Article ORIGINAL R ESEARC H Microcurrent stimulation in the treatment of dry and wet macular degeneration Laurie Chaikin1 Purpose: To determine the safety and efficacy of the application of transcutaneous Kellen Kashiwa2 (transpalpebral) microcurrent stimulation to slow progression of dry and wet macular degenera- Michael Bennet2 tion or improve vision in dry and wet macular degeneration. George Papastergiou3 Methods: Seventeen patients aged between 67 and 95 years with an average age of 83 years Walter Gregory4 were selected to participate in the study over a period of 3 months in two eye care centers. There were 25 eyes with dry age-related macular degeneration (DAMD) and six eyes with wet 1Private practice, Alameda, CA, USA; 2Retina Institute of Hawaii, age-related macular degeneration (WAMD). Frequency-specific microcurrent stimulation was Honolulu, HI, USA; 3California Retinal applied in a transpalpebral manner, using two programmable dual channel microcurrent units Associates, San Diego, CA, USA; delivering pulsed microcurrent at 150 MA for 35 minutes once a week. The frequency pairs 4Clinical Trials Research Unit, Faculty of Medicine and Health, University of selected were based on targeting tissues, which are typically affected by the disease combined Leeds, Leeds, UK with frequencies that target disease processes. Early Treatment Diabetic Retinopathy Study or Snellen visual acuity (VA) was measured before and after each treatment session.
  • The Primate Model for Understanding and Restoring Vision

    The Primate Model for Understanding and Restoring Vision

    The primate model for understanding and restoring vision Serge Picauda,1, Deniz Dalkaraa,1, Katia Marazovaa, Olivier Goureaua, Botond Roskab,c,d,2, and José-Alain Sahela,e,f,g,2 aInstitut de la Vision, INSERM, CNRS, Sorbonne Université, F-75012 Paris, France; bInstitute of Molecular and Clinical Ophthalmology Basel, CH-4031 Basel, Switzerland; cFaculty of Medicine, University of Basel, 4056 Basel, Switzerland; dFriedrich Miescher Institute, 4058 Basel, Switzerland; eDepartment of Ophthalmology, The University of Pittsburgh School of Medicine, Pittsburgh, PA 15213; fINSERM-Centre d’Investigation Clinique 1423, Centre Hospitalier National d’Ophtalmologie des Quinze-Vingts, F-75012 Paris, France; and gDépartement d’Ophtalmologie, Fondation Ophtalmologique Rothschild, F-75019 Paris, France Edited by Tony Movshon, New York University, New York, NY, and approved October 18, 2019 (received for review July 8, 2019) Retinal degenerative diseases caused by photoreceptor cell death provide highly responsive and reliable models for in-depth are major causes of irreversible vision loss. As only primates have a functional studies. Furthermore, brain-imaging studies de- macula, the nonhuman primate (NHP) models have a crucial role scribing visual cortex activity aid our understanding of the vi- not only in revealing biological mechanisms underlying high-acuity sual system and its functions and also serve as important tools vision but also in the development of therapies. Successful trans- for studying the brain (5–8). lation of basic research findings into clinical trials and, moreover, approval of the first therapies for blinding inherited and age- Uniqueness of the Primate Model for Human Vision related retinal dystrophies has been reported in recent years.
  • 2020-SEI-AR Redact Edit.Pdf

    2020-SEI-AR Redact Edit.Pdf

    1 1 SIMPLY WORLD CLASS The Viterbi Family Department of Ophthalmology and the Shiley Eye Institute at UC San Diego offers treatment across all areas of eye care. Our world class clinicians, surgeons, scientists and staff are dedicated to excellence and providing the best possible patient care to prevent, treat and cure eye diseases. Our research is at the forefront of developing new methods to diagnose and treat eye diseases and disorders. In addition to educating the leaders of tomorrow, we are committed to serving the San Diego and global community. 2 2 C O N T E N T S 10 16 LETTERS 4 EXECUTIVE COMMITTEE 7 YEAR IN REVIEW 9 COVID-19 10 HIGHLIGHTS OF THE YEAR 20 21 36 FACULTY 46 RESIDENTS & FELLOWS 59 SIMPLY WORLD CLASS EDUCATION 62 PUBLICATIONS & GRANTS 72 GIVING 86 FRONT COVER IMAGE: Transmission electron microscopic image of an isolate from the first U.S. case of COVID-19, formerly known as 2019-nCoV. The spherical viral particles, colorized blue, contain cross-section through the viral genome, seen as black dots. 3 3 Letter from the Chancellor Dear Friends, In this especially challenging year, tional vision care and expertise. This report is filled with news UC San Diego is innovating to and stories from the past year that illustrate a holistic ap- meet the needs of our students proach to improving vision health through patient-centered and patients and adjusting to our care, leading-edge collaborative research, and community new reality so we can maintain our outreach. We are incredibly grateful for your contributions to- pursuit of groundbreaking discov- ward these efforts, and for the lasting impact you are making eries.
  • Sacroiliac Joint Injury and Dysfunction: an Overlooked Cause of Low Back and Buttock Pain

    Sacroiliac Joint Injury and Dysfunction: an Overlooked Cause of Low Back and Buttock Pain

    Sacroiliac Joint Injury and Dysfunction: An overlooked cause of Low Back and Buttock Pain. Author: Shannon P. Goossen, AP, LMT, CMTPT- 2003 The sacroiliac joint can be the cause of debilitating low back and buttock pain. It can additionally be the culprit of pseudo-sciatica, which was described by Smith- Peterson in 1926. Unfortunately, in as much as muscles are the “orphan organ” in the diagnosis of chronic pain, the sacroiliac joint is the “orphan joint” in the differential diagnosis of spinal disorders and low back pain. What is more disturbing is that in order to effectively treat SIJ injury and dysfunction, one must have an understanding of both myofascial and joint dysfunction. This could easily explain the controversy in evaluation, diagnosis and treatment. Fortunately, studies in the last decade have validated that the SIJ may be the primary pain generator in up to 30% of patients reporting low back pain below the level of L5 –S1 (Schwarzer, A et. al). Other studies and physicians treating SIJ have supported this conclusion as well. The sacroiliac joint is complex. It has the characteristics of a synovial joint with hyaline cartilage lining the sacral side of the joint, and fibrocartilage lining the ilial side of the joint. It is also defined as a synarthrosis and amphiarthrosis. It has more mobility early in life, and generally between 40-50 years of age, degenerative changes take place, and the joint stiffens in men and women. Although the actual amount of movement in the SIJ has been a source of controversy, up to 4 degrees of rotation and 1.6 mm of translation is expected in young adults (Vleeming et.
  • Thumb Carpometacarpal Arthritis 952-920-0970

    Thumb Carpometacarpal Arthritis 952-920-0970

    Douglas Drake, MD Orthopedic Surgeon and Hand Specialist 3250 W. 66th St. Suite #100 Edina, MN 55435 Thumb Carpometacarpal Arthritis 952-920-0970 Thumb CMC Arthritis: Idiopathic thumb basal joint aka thumb CMC arthritis StageIII: Continued joint narrowing with cystic changes is a result of anatomic factors that predispose the CMC and sclerotic bone formarion. Prominent osteophytes joint instability, such as joint configuration and ligamen- are present wiht moderate subluxation at the cmc joint tous laxity. CMC joint instability results in shear forces and subluxation at the MCP joint. at the joint surfaces and subsequent joint degeneration. Stage IV: All the components of stage III along with destruction of the scaphotrapezial joint. At this stage the CMC joint is usually fixed and some patients may have little to no pain. Treatment: In early stages, stage I and sometimes stage II, con- servative treatment should be considered. Conservative treatment consists of a period of thumb immobilization in a removable splint, see picture below, and use of NSAID’s. If splinting fails to relieve the pain then a corticosteroid injection may be performed. Of note, corticosteroid injections will not alter the progression of Prevalence: the disease but it may provide a few months of relief. Idiopathic thumb CMC arthritis is most common If conservative treatment fails to provide relief and pain amount women 40-70 years old. Women are 15 to 20 is making it difficult for the patient to perform daily times more likely than men to have thumb CMC arthri- functions or disease has progressed to stage III or IV tis; this is most likely secondary to increased joint laxity then surgical treatment in healthy patients should be found in women when compared to men.
  • Ucla Stein Eye Institute Vision-Science Campus

    Ucla Stein Eye Institute Vision-Science Campus

    SPRING 2020 VOLUME 38 NUMBER 1 UCLA STEIN EYE INSTITUTE EYEVISION-SCIENCE CAMPUS LETTER FROM THE CHAIR To have 20/20 vision is to see clearly, and for the UCLA Department of Ophthalmology, the year 2020 heralds in both a new decade and a focus on our mission to preserve sight and end avoidable blindness. Research is core to this aim, and in this issue of EYE Magazine, we highlight basic scientists in the UCLA Stein Eye Institute’s Vision Science Division who are studying the fundamental mechanisms of visual function and using that knowledge to define, identify, and ultimately cure eye disease. Clinical research trials are also underway at Stein Eye and the Doheny Eye Centers UCLA, and include the first in-human trial of autologous cultivated limbal cell therapy to treat limbal stem cell deficiency, a blinding corneal disease; evaluation of an investiga- tional medication to treat graft-versus-host disease, a potentially EYE MAGAZINE is a publication of the serious complication after transplant procedures; comparison of UCLA Stein Eye Institute drug-delivery systems to determine which is most effective for DIRECTOR treatment of diabetic macular edema; and analysis of regenerative Bartly J. Mondino, MD strategies for treatment of age-related macular degeneration. MANAGING EDITOR UCLA Department of Ophthalmology award-winning researchers Tina-Marie Gauthier conduct investigations of depth and magnitude, and the Depart- c/o Stein Eye Institute 100 Stein Plaza, UCLA ment has taken a central role in transforming vision science as a Los Angeles, California 90095–7000 powerful platform for discovery. I thank our faculty and staff for their [email protected] sight-saving endeavors, and I thank you, our donors and friends, for PUBLICATION COMMITTEE supporting our scientific explorations.
  • Springer Clinical Medicine Preview Top Frontlist October – December 2013

    Springer Clinical Medicine Preview Top Frontlist October – December 2013

    ABC springer.com Springer Clinical Medicine Preview Top Frontlist October – December 2013 FOURTH QUARTER 2013 springer.com New Publications at the Forefront of Research & Development Dear reader, This catalog is a special selection of new book publications from Springer in the fourth quarter of 2013. It highlights the titles most likely to interest specialists working in the professional field or in academia. You will find the international authorship and high quality contributions you have come to expect from the Springer brand in every title. Please show this catalog to your buyers and acquisition staff. It is a premier and most authoritative source of new print book titles from Springer. We offer you a wide range of publication types – from contributed volumes focusing on current trends, to handbooks for in-depth research, to textbooks for graduate students. If you are looking for something very specific, go to our online catalog at springer.com and search among the 83,000 English books in print by keyword. The Advanced Search makes it easy to define any scientific subject you have. You can even download a catalog just like this one with your own personal selection – completely free of charge! We hope you will enjoy browsing through our new titles and make your selection today! With best wishes, Matthew Giannotti Product Manager, Trade Marketing P.S. Register on springer.com for automatic New Book Alerts by subject. If you register as a bookseller, you will also receive the monthly Bookseller Alert that announces every new title by subject in the Springer NEWS catalog. Legend Book with online Book CD-ROM Textbook files/update with CD-ROM Book DVD Set with DVD springer.com Medicine | Anaesthesiology B.
  • Marfan Syndrome: Jeffrey Welder MSIII, Erik L

    Marfan Syndrome: Jeffrey Welder MSIII, Erik L

    Marfan Syndrome: Jeffrey Welder MSIII, Erik L. Nylen MSE, Thomas Oetting MS MD May 6, 2010 Chief Complaint: Decreased vision and glare in both eyes. History of Present Illness: A 28 year old woman with a history of Marfan syndrome presented to the comprehensive ophthalmology clinic reporting a progressive decrease in vision and worsening glare in both eyes. She had been seen by ophthalmologists in the past, and had been told that her crystalline lenses were subluxed in both eyes. She had not had problems with her vision until recent months. Past Medical History: Marfan syndrome with aortic stenosis followed by cardiology Medications: Oral beta blocker Family History: No known family members with Marfan Syndrome. Grandmother with glaucoma. Social History: The patient is a graduate student. Ocular Exam: External Exam normal. VA (with correction): OD 20/40 OS 20/50 Current glasses: OD: 6.75+ 5.00 x 135 OS: -5.25 + 4.25 x 60 Pupils: No anisocoria and no relative afferent pupillary defect Motility: Ocular motility full OU. Anterior segment exam: Inferiorly subluxed lenses OU (figure 1 and 2). The angle was deep OU and there was no lens apposition to the cornea in either eye. Dilated funduscopic exam: Posterior segment was normal OU with no peripheral retinal degeneration . Course: The patient’s subluxed lenses led to poor vision from peripheral lenticular irregular astigmatism and glare. She was taken to the operating room where her relatively clear lenses were removed and iris sutured intraocular lenses were placed. The surgical video for one of the eyes may be viewed at http://www.facebook.com/video/video.php?v=153379281140 Page | 1 Figure One: Note the inferiorly subluxed lens.